相互作用
Efgartigimod alfa + Galcanezumab
重症度: 中等度
Efgartigimod alfa and Galcanezumab: moderate interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Efgartigimod blocks the neonatal Fc receptor, which normally protects IgG from degradation. Galcanezumab is an IgG4 monoclonal antibody, so its levels could fall and its migraine-preventive effect could weaken. Clinical data for this specific combination are lacking.
この相互作用をわかりやすく説明すると
Efgartigimod alfa and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Efgartigimod alfa belongs to Miscellaneous; Galcanezumab belongs to Central Nervous System.
なぜ起こるのか
FcRn blockade by efgartigimod increases catabolism of IgG-based antibodies such as galcanezumab.
対処法
Monitor migraine control and consider a change in preventive therapy if efficacy declines. Time galcanezumab doses with awareness that efficacy may fall during efgartigimod treatment.
薬剤師に尋ねること
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Efgartigimod alfaとGalcanezumabの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Galcanezumabのその他の相互作用
Efgartigimod alfaのその他の相互作用
よくある質問
Can I take Efgartigimod alfa with Galcanezumab?
MediHelp rates the interaction as moderate. Efgartigimod alfa and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks the neonatal Fc receptor, which normally protects IgG from degradation. Galcanezumab is an IgG4 monoclonal antibody, so its levels could fall and its migraine-preventive effect could weaken. Clinical data for this specific combination are lacking.
How serious is the interaction between Efgartigimod alfa and Galcanezumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor migraine control and consider a change in preventive therapy if efficacy declines. Time galcanezumab doses with awareness that efficacy may fall during efgartigimod treatment.
What other medicines interact with Galcanezumab?
MediHelp also lists interactions of Galcanezumab with, for example, Efgartigimod / hyaluronidase sc, Rozanolixizumab. The full list is on the Galcanezumab page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
